News

Greenwood Genetic Center Receives Funding for Alzheimer's Research

WHNS Fox Carolina reported on the Greenwood Genetic Center receiving $2 million for Alzheimer's Disease research. This funding is...

MitoSense Joins CAMP as Partner for Advanced Therapy Medicinal Products (ATMPs) Development

PLYMOUTH, Mass., July 24, 2023 /PRNewswire/ -- MitoSense and the Centre for Advanced Medical Products (CAMP) are delighted to announce...

Funding for mitochondrial treatment research on Alzheimer’s disease in SC Governor's budget proposal

GREENWOOD, S.C. (FOX Carolina) -- The Greenwood Genetics Center in Greenwood, SC is looking to study MitoSense's MOT™ technology and its...

MitoSense and Uppsala University's Centre for Transplantation Technology Enter into Strategic MOU

GREAT FALLS, Va., Dec. 21, 2022 /PRNewswire/ -- Today, Uppsala University's Centre for Transplantation Technology (CTTM) and US-based...

MitoSense and U.S. Dept. of Veterans Affairs Selected to Present Science at Major Medical Conference

GREAT FALLS, Va., Sept. 12, 2022 /PRNewswire/ -- MitoSense, Inc., a life-science company focused on harnessing the power of mitochondria...

MitoSense Names Former U.S. Ambassador to Switzerland, Ed McMullen, as Senior Advisor to Board

GREAT FALLS, Va., June 9, 2022 /PRNewswire/ -- MitoSense, Inc., a life-science company focused on harnessing the power of mitochondria to...

MitoSense's CRADA and ALS Work Recognized in Congressional Record

U.S. Congressman Neal Dunn publicly recognized work related to MitoSense's research and development of treatments for amyotrophic lateral...

MitoSense and the U.S. Department of Veterans Affairs Enter into Agreement (CRADA)

MitoSense has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Veterans Affairs (VA).